Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Shao

Showing results (1041-1050 of 1,142) with videos related to

Pageof 115
Sort By:
Cancer Cell|January 8, 2019
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR SignalingMinhong Shen, Yi-Zhou Jiang, Yong Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
Stress-Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast CanceZhibo Shao, Xuliren Wang, Han Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2025
LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast CancerQi Zhang, Xuliren Wang, Zhibo Shao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2021
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2Ming-Shao Tsai, Yao-Hsu Yang, Yu-Shih Lin, et al.
Scientific Reports|June 5, 2024
Prognostic importance of modified geriatric nutritional risk index in oral cavity squamous cell carcinomaYao-Te Tsai, Ming-Hsien Tsai, Geng-He Chang, et al.
Theranostics|October 12, 2020
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancerBi Lian, Yu-Chen Pei, Yi-Zhou Jiang, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2021
Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 DiabetesResham Lal Gurung, Rajkumar Dorajoo, Yiamunaa M, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 11, 2020
IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 StabilityLixing Zhang, Jiankun Qiang, Xiaoli Yang, et al.
International Journal of Cancer|March 16, 2017
The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencingGuan-Tian Lang, Jin-Xiu Shi, Xin Hu, et al.
Biomarker Research|January 9, 2025
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancerXin-Yi Sui, Shuo-Wen Cao, Xiao-Qing Song, et al.
Pageof 115

Showing results (1041-1050 of 1,142) with videos related to

Sort By:
Pageof 115
Cancer Cell|January 8, 2019
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR SignalingMinhong Shen, Yi-Zhou Jiang, Yong Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
Stress-Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast CanceZhibo Shao, Xuliren Wang, Han Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2025
LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast CancerQi Zhang, Xuliren Wang, Zhibo Shao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2021
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2Ming-Shao Tsai, Yao-Hsu Yang, Yu-Shih Lin, et al.
Scientific Reports|June 5, 2024
Prognostic importance of modified geriatric nutritional risk index in oral cavity squamous cell carcinomaYao-Te Tsai, Ming-Hsien Tsai, Geng-He Chang, et al.
Theranostics|October 12, 2020
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancerBi Lian, Yu-Chen Pei, Yi-Zhou Jiang, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2021
Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 DiabetesResham Lal Gurung, Rajkumar Dorajoo, Yiamunaa M, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 11, 2020
IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15-Dependent BMI1 StabilityLixing Zhang, Jiankun Qiang, Xiaoli Yang, et al.
International Journal of Cancer|March 16, 2017
The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencingGuan-Tian Lang, Jin-Xiu Shi, Xin Hu, et al.
Biomarker Research|January 9, 2025
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancerXin-Yi Sui, Shuo-Wen Cao, Xiao-Qing Song, et al.
Pageof 115